Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | PLK1 | P53350 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 2/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.41 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.41 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29954168 | 0.83 | ERN1 (0.50) | GAAPLK1TRIM24TRIM33BRD4 | |
| SCHEMBL7194219 | 0.83 | ERN1 (0.50) | GAAPLK1TRIM24TRIM33BRD4 | |
| SCHEMBL4903302 | 0.82 | GAA (0.53) | GAAPLK1ALDH1A1BRD4KAT2B | |
| SCHEMBL7542943 | 0.82 | GAA (0.55) | GAAMEN1LMNATHRBBLM | |
| SCHEMBL1932685 | 0.82 | MEN1 (0.48) | GAAMEN1LMNATHRBBLM | |
| SCHEMBL18467750 | 0.81 | SLC6A2 (0.47) | GAAPLK1MEN1LMNATHRB | |
| SCHEMBL31482074 | 0.81 | GAA (0.49) | GAAPLK1MEN1LMNAKMT2A | |
| SCHEMBL23346944 | 0.81 | GAA (0.52) | GAAPLK1BRD4KAT2BBAZ2B | |
| SCHEMBL30954205 | 0.81 | GAA (0.52) | GAAPLK1BRD4KAT2BBAZ2B | |
| SCHEMBL7807778 | 0.81 | GAA (0.52) | GAAPLK1BRD4KAT2BBAZ2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024130673-A1 | POLYMER AND PREPARATION METHOD THEREFOR | 深圳华大生命科学研究院 | 2024-06-27 | — | — | WO | disclosed |
| WO-2023219085-A1 | FLUORINATED POLYAMIDE COMPOUND, FLUORINATED POLYIMIDE COMPOUND, LOW DIELECTRIC MATERIAL, AND HIGH-FREQUENCY ELECTRONIC COMPONENT | ダイキン工業株式会社 | 2023-11-16 | — | — | WO | disclosed |
| WO-2023177842-A1 | COPPER-CATALYZED AMIDATION OF POLYOLEFINS | BASF CORPORATION (US) | 2023-09-21 | — | — | WO | disclosed |
| WO-2021209765-A2 | METHODS AND PRODUCTS | THE UNIVERSITY OF BIRMINGHAM (GB) | 2021-10-21 | — | — | WO | disclosed |
| EP-3805237-A1 | SYNTHESIS AND USES OF PEPTIDE BORATE ESTER COMPOUND | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CN) | 2021-04-14 | — | — | EP | disclosed |
| WO-2020189519-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND | 国立大学法人九州大学 | 2020-09-24 | — | — | WO | disclosed |
| EP-3543227-A1 | FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | Guangdong Zhongsheng Pharmaceutical Co., Ltd (CN) | 2019-09-25 | — | — | EP | disclosed |
| EP-3114128-B1 | NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN LA ROCHE (CH) | 2019-01-02 | — | — | EP | disclosed |
| US-9926267-B2 | Covalent inhibitors of K-Ras G12C | ARAXES PHARMA LLC (US) | 2018-03-27 | — | — | US | disclosed |
| EP-2934135-B1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2018-01-31 | — | — | EP | disclosed |
| EP-1858976-B1 | NOVEL POLYMERS | BASF SE (DE) | 2009-10-14 | — | — | EP | disclosed |
| WO-2009087153-A1 | TRICYCLIC NITROGEN COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS | GLAXO GROUP LIMITED (GB) | 2009-07-16 | — | — | WO | disclosed |
| US-7425557-B2 | Inhibitors of glycogen synthase kinase 3 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2008-09-16 | — | — | US | disclosed |
| WO-2008104696-A2 | POLYMER PARTICLE DISPERSION, COMPOSITION CONTAINING THE SAME AND COSMETIC TREATMENT METHOD | L'OREAL (FR) | 2008-09-04 | — | — | WO | disclosed |
| WO-2008088336-A1 | COATED ARTICLES OF MANUFACTURE MADE OF HIGH Tg POLYMER BLENDS | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008009700-A1 | DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES | GLAXO GROUP LIMITED (GB) | 2008-01-24 | — | — | WO | disclosed |
| EP-1556360-B1 | ELECTROLUMINESCENT DEVICE | CIBA SC HOLDING AG (CH) | 2008-01-23 | — | — | EP | disclosed |
| WO-2008006648-A1 | SUBSTITUTED 1-METHYL-1H-QUINOLIN-2-ONES AND 1-METHYL-1H-1,5-NAPHTHYRIDIN-2-ONES AS ANTIBACTERIALS | GLAXO GROUP LIMITED (GB) | 2008-01-17 | — | — | WO | disclosed |
| WO-2007059445-A2 | SYNERGISTIC COMBINATIONS OF NORKETAMINE AND OPIOID ANALGESICS | YAUPON THERAPEUTICS, INC. (US) | 2007-05-24 | — | — | WO | disclosed |
| US-7179802-B2 | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia | MERCK & CO., INC. (US) | 2007-02-20 | — | — | US | disclosed |